Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Molecular Partners Ag (MOLN) Cash from Operations: 2019-2024

Historic Cash from Operations for Molecular Partners Ag (MOLN) over the last 6 years, with Dec 2024 value amounting to -$67.3 million.

  • Molecular Partners Ag's Cash from Operations fell 0.25% to $37.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$66.4 million, marking a year-over-year decrease of 107.84%. This contributed to the annual value of -$67.3 million for FY2024, which is 2.51% down from last year.
  • Molecular Partners Ag's Cash from Operations amounted to -$67.3 million in FY2024, which was down 2.51% from -$65.7 million recorded in FY2023.
  • In the past 5 years, Molecular Partners Ag's Cash from Operations registered a high of $123.1 million during FY2022, and its lowest value of -$98.6 million during FY2021.
  • Its 3-year average for Cash from Operations is -$3.3 million, with a median of -$65.7 million in 2023.
  • In the last 5 years, Molecular Partners Ag's Cash from Operations tumbled by 2,578.25% in 2020 and then soared by 224.77% in 2022.
  • Over the past 5 years, Molecular Partners Ag's Cash from Operations (Yearly) stood at -$32.1 million in 2020, then crashed by 207.67% to -$98.6 million in 2021, then spiked by 224.77% to $123.1 million in 2022, then plummeted by 153.38% to -$65.7 million in 2023, then fell by 2.51% to -$67.3 million in 2024.